A practical reference on synaptogenesis: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2025-12-02. Anything still debated is marked as such rather than presented as settled.
Dihexa is a synthetic peptide with the chemical name N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, and it is structurally related to angiotensin IV, a naturally occurring peptide fragment. Researchers developed it as a modified analog intended to alter stability and activity relative to the parent peptide. Its short sequence and fatty acid chain distinguish it from many endogenous peptides, and published studies often describe it under the abbreviation dihexa. The compound is classified as a laboratory compound rather than an approved therapeutic in most jurisdictions.
Early laboratory work focused on its effects on synaptic connectivity and neuronal signaling. In cell and animal models, dihexa has been reported to promote the formation of new synapses, a process called synaptogenesis. These findings have generated interest in cognitive research, but the evidence base remains mostly preclinical. Human clinical trials with clear safety and efficacy endpoints are limited or absent in the public literature. Whether these effects translate to humans is an open question.
The proposed mechanism involves interaction with the hepatocyte growth factor (HGF) system and its receptor, c-Met. Dihexa is described in some studies as an HGF mimetic, meaning it may mimic or enhance HGF-mediated signaling. Activation of c-Met can influence cell growth, survival, and cytoskeletal remodeling, pathways that intersect with synaptic plasticity. However, the precise binding targets and downstream events for dihexa are not fully established, and alternative mechanisms have been suggested.
The angiotensin IV connection places dihexa in a family of short peptides studied for effects on central nervous system signaling. Angiotensin IV itself is a metabolite of angiotensin II, and analogs have been explored in cardiovascular and neurological research. Dihexa differs from the natural peptide through structural modifications intended to alter stability and receptor interactions. Published descriptions sometimes call it a hepatocyte growth factor mimetic, although that label reflects proposed activity rather than a confirmed clinical mechanism.
Identity checks for dihexa usually rely on mass spectrometry and chromatographic purity analysis. A lyophilized powder is the common supplied form, and it may appear as a white to off-white solid. Aqueous solubility is limited, so laboratory work often uses an organic solvent such as dimethyl sulfoxide to prepare stock solutions. Because the peptide is not a standard pharmaceutical product, exact specifications can vary between suppliers. Certificates of analysis may accompany a batch, but they are not equivalent to regulatory approval.
Dihexa is a synthetic peptide whose structure is modeled on angiotensin IV. Its chemical name often appears as N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, though vendor and publication naming can differ. The molecule combines a short amino acid sequence with a hexanoic acid group and an amide terminus. It is classed as a small research peptide rather than a conventional drug. Databases may list it under several synonyms, so matching names are important when comparing sources.
| Property | Value | Notes |
|---|---|---|
| Chemical name | N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide | Common full name in research literature. |
| Class | Synthetic peptide | Modified angiotensin IV analog. |
| Related compound | Angiotensin IV | Parent peptide fragment. |
| Proposed target | HGF/c-Met pathway | Described as an HGF mimetic; not fully confirmed. |
| Development status | Preclinical research | No widely approved clinical use. |
Human data for dihexa remain absent from peer-reviewed clinical literature. As a result, questions about absorption, distribution, metabolism, excretion, and long-term safety are unresolved. Discussions often appear in nootropic forums, where anecdotal reports cannot substitute for controlled trials. Researchers have called for more rigorous pharmacokinetic and toxicological studies before any clinical evaluation. Until such data exist, dihexa is best described as an investigational research compound rather than a proven intervention.
The proposed mechanism for dihexa centers on hepatocyte growth factor, or HGF, and its receptor c-Met. HGF signaling is involved in cell growth, survival, and synapse formation. Dihexa has been described as an HGF mimetic or modulator in preclinical literature. Whether it binds c-Met directly, increases HGF availability, or acts through another route remains uncertain. This mechanistic uncertainty is a recurring theme in reviews of the compound, and no single molecular model has been confirmed across independent laboratories.
Research on dihexa has primarily used rodent models and cultured cells. Common endpoints include dendritic spine density, synaptic protein expression, and performance on maze or avoidance tasks. Some studies report improvements in cognitive measures after scopolamine-induced deficits or in aged animals. These findings are interesting but come from a small body of work, and independent laboratories have not consistently replicated all reported effects. Larger, preregistered studies would help clarify which results are robust.
Dihexa is not approved for human use in the United States or the European Union. It is commonly sold as a research chemical, a category that may not require the same regulatory review as medicines. Buyers should note that product labels may lack independent verification of identity or purity. The legal status can vary by country, and importation may be restricted. Reliable information about sourcing and quality is often scarce. Scientific publications typically use synthesized material from laboratories rather than commercial consumer products.
Dihexa is a synthetic peptide studied in laboratory research. It is often described as an angiotensin IV analog or a hepatocyte growth factor mimetic. The compound emerged from investigations into angiotensin IV and its effects on neural pathways. It is not an approved medication, and controlled human trials are lacking. In literature and online forums, it is discussed mainly as a research chemical. Its chemical name appears as N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) in some sources.
As a concession made by Lamartine to popular aspirations, and in exchange for the maintaining of the tricolor flag, he conceded the Republican triptych of Liberté, Égalité, Fraternité, written on the flag, on which a red rosette was also to be added. The first collision took place as to the form which the 1848 Revolution was to take. Lamartine wished for them to maintain their original principles, with the whole country as supreme, whereas the revolutionaries under Ledru-Rollin wished for the Republic of Paris to hold a monopoly on political power. On 5 March the government, under the pressure of the Parisian clubs, decided in favor of an immediate reference to the people, and direct universal suffrage, and adjourned it until 26 April. This added the uneducated masses to the electorate and led to the election of the Constituent Assembly on 4 May 1848. The provisional government having resigned, the republican and anti-socialist majority on 9 May entrusted the supreme power to an Executive Commission consisting of five members: Arago, Pierre Marie de Saint-Georges, Garnier-Pagès, Lamartine, and Ledru-Rollin. The result of the general election, the return of a predominantly moderate, if not monarchical, constituent assembly dashed the hopes of those who had looked for the establishment, by a peaceful revolution, of their ideal socialist state. but they were not prepared to yield without a struggle, and in Paris itself they commanded a formidable force.
The percentage of cases for the Home Nations are shown as follows: 2.66% in England (1 in 40 people), 2.41% in Wales (1 in 40 people), 1.42% in Northern Ireland (1 in 70 people), and 2.59% in Scotland (1 in 40 people). 25 March A special Honours list is announced to recognise those who played a role in the state funeral of Elizabeth II, including the eight pallbearers who carried the Queen's coffin during the ceremony. Reports in The Sun and i newspapers suggest former prime minister Liz Truss, who was in office for 49 days, has submitted a Resignation Honours list. BBC Two airs The MI5 Spy and the IRA: Operation Chiffon, a programme in which journalist Peter Taylor reveals the story of an MI5 spy who helped bring about the Northern Ireland Peace Process after defying government orders not to hold talks with Provisional IRA representatives in 1993. 26 March A ban on the possession of nitrous oxide ("laughing gas"), which is typically purchased in small glass phials, is announced. The government justifies its action as part of a crackdown on anti-social behaviour, going against recommendations from the Advisory Council on the Misuse of Drugs which had recently advised against criminalisation of the gas. The 2023 Boat Race takes place, with Cambridge beating Oxford in both the men's and women's races. 27 March Humza Yousaf succeeds Nicola Sturgeon as Leader of the SNP, after defeating rivals Kate Forbes and Ash Regan in a leadership election.
After the lipids are separated on the GC or LC column they are detected using mass spectrometry (MS). Mass spectrometry characterizes the mass of a given molecule by first fragmenting and ionizing the molecule into smaller carbocations known as daughter ions. Each molecule has a diagnostic fragmentation pattern in a given ion source. Classes of molecules often have a characteristic fragment ion that can be used to search for those molecules in a total ion current. This is known as a selected ion chromatogram (SIC). SICs are used in single quadrupole mass spectrometers. When two quadrupoles are attached in tandem mass spectrometry (MS/MS), two mass fragments can be isolated simultaneously. MS/MS experiments allow the total ion current to be filtered by both the molecular ion and the characteristic fragment ion of a given molecule. The molecular ion of gammacerane with an electron impact source is 412 m/z. Like other pentacyclic triterpenoids, it has a characteristic 191 m/z mass fragment. The combination of 412 m/z and 191 m/z is known as the 412-->191 m/z transition and can be used to search a chromatogram specifically for gammacerane.
== Clinical significance == Altered PREP activity may be associated with autism spectrum disorders and various psychological diseases such as schizophrenia, mania and clinical depression. However, there is conflicting information as to the exact role that prolyl endopeptidase plays in the pathophysiology of depression, with earlier studies documenting a decreased activity of the enzyme in depressed patients, but more recent studies demonstrating that inhibition of the same enzyme actually results in alleviation of depressive symptoms. Some types of prolyl endopeptidase have been used in studies to decrease the propensity of gluten-containing wheat products to aggravate coeliac disease. However, orally administered enzymes are potentially subject to inactivation in the gastrointestinal tract.
Sources: en.wikipedia.org
=== Vitamin B12 === Spirulina contains no vitamin B12 naturally, and spirulina supplements are not considered a reliable source of vitamin B12, as they contain predominantly pseudovitamin B12 (Coα-[α-(7-adenyl)]-Coβ-cyanocobamide), which is biologically inactive in humans. In a 2009 position paper on vegetarian diets, the American Dietetic Association stated that spirulina is not a reliable source of active vitamin B12. The medical literature similarly advises that spirulina is unsuitable as a source of B12.
== In popular culture == The 1990 film Reversal of Fortune depicts the case and its surrounding fallout. For his portrayal of Claus von Bülow, Jeremy Irons won the Academy Award for Best Actor. Klaus and Sunny Baudelaire from A Series of Unfortunate Events are named after Claus and Sunny von Bülow.
=== Biomimetic compounds === Our understanding of the mechanism of galactose oxidase inspires researchers to develop model compounds that mimics the structure and function of galactose oxidase. It appears that electron-sharing between the copper and the free radical is the crucial element in the success of synthesizing these compounds. The first model compound of GAOX made is [Cu(II)(dnc)], which utilizes duncamine (dnc) as the chelating ligand. Other model compounds have been studied and reported in literature.
== Publications == 1922: Researches on the insect metamorphosis. Doctoral Thesis on the histology of metamorphosis of the Chalcid wasp, Nasonia. 1922: On the arrangement of the striations of voluntary muscle fibres in double spirals. 1932: "The Innervation of the Striated Musculature in Python", The Australian Journal of Experimental Biology and Medical Science, Vol.9, No.1, (January 1932), pp. 191-201. 1938: Memoirs: The Embryonic Development of Calandra oryzae. (with Florence V. Murray) see Sitophilus oryzae the rice weevil. 1942: The ‘Dorsal Organ’ of the Embryo of Campodea. 1945: Memoirs: The Post-Embryonic Development of Hanseniella agilis (Symphyla). 1947: The development and affinities of the Pauropoda, based on a study of Pauropus silvaticus. 1955: The Path of the Slow Contractile Wave in Arthropod Muscle Fibre. (with E. Matthaei) Photographic records are consistent with the hypothesis that the slow waves move along the helicoid.
In biology, tissue is an assembly of similar cells and their extracellular matrix from the same embryonic origin that together carry out a specific function. Tissues occupy a biological organizational level between cells and a complete organ. Accordingly, organs are formed by the functional grouping of multiple tissues. The English word "tissue" derives from the French word "tissu", meaning "fabric", derived from the verb “tisser”, "to weave". The study of tissues is known as histology or, in connection with disease, as histopathology. Xavier Bichat is considered as the "Father of Histology". Plant histology is studied in both plant anatomy and physiology. The classical tools for studying tissues are the paraffin block in which tissue is embedded and then sectioned, the histological stain, and the optical microscope. Developments in electron microscopy, immunofluorescence, and the use of frozen tissue-sections have enhanced the detail that can be observed in tissues. With these tools, tissues can be examined in health and disease, allowing accurate medical diagnosis and prognosis.
Sources: en.wikipedia.org
== Signs and symptoms == The clinical findings in all three CCDs result from the consequences of decreased levels of creatine in tissues where it is required. In affected individuals with any of the three disorders, there is an almost complete absence of creatine and phosphocreatine in the brain. The two tissues with the highest demands for creatine are the brain and skeletal muscles. Muscular findings usually include weakness and decreased endurance. Other clinical findings include seizures, intellectual disability and developmental delay. Most affected individuals appear normal at birth, with clinical findings becoming apparent during the first year of life, and progressing.
==== Eps and Singles ==== "I Dreamed I Dream" - Split 7'/10" With Melvins - (Boner/Tupelo, 1989) "Arizona Garbage Truck / Voodoo Chile" (Sympathy for the Recording Industry, 1990) "European Son / Venus in Furs" (The Communion Label, 1991) "We Walk" - Split 7" with Jawbreaker - (Staple Gun Records, 1991) "Your Choice Live" - Limited 7" - (Your Choice Records, 1991) "Bozeman" (Boner/Tupelo, 1992) "Some Cocktail Suggestions EP" (Boner/Tupelo, 1994) "Tragedy Ecstasy Doom and So On EP" (Genius Records, 1995) "Auf Wiedersehen / Surrender" (Man's Ruin Records, 1995) "Twist / Surrender" (Slash Records, 1995) "Hey Bo Diddley Live in Tokyo" - Split 7" with Unwound - (Honey Bear Records, 1996) "Soul Cannon" - "Live at Emo's: Volume 2 - #2: This Place Sucks" - Split 7" with "Unsane" / "Gomez" - (No Lie Records, 1997)
=== School lunches === The reaction against the product has also been partially credited to a Change.org petition that has landed over a quarter million signatures to ban it in school meals. After some parents and consumer advocates insisted the product be removed from public schools, the USDA indicated, beginning in fall 2012, that it would give school districts the choice between ground beef with or without LFTB. CBS News reported that Chicago Public schools may have served "pink slime" in school lunches. While some school districts have their own suppliers, many school districts purchase beef directly from the USDA and do not know what is in the beef. For the year 2012, the USDA planned on purchasing 7 million pounds of lean beef trimmings for the U.S. national school lunch program. USDA spokesman Mike Jarvis stated that of the 117 million pounds of beef ordered nationally for the school lunch program in the past year, 6% was LFTB. An analysis of California Department of Education data indicated that "anywhere from none to nearly 3 million pounds of beef from the USDA that was served in California schools last year could have contained lean finely textured beef". According to the USDA, the cost differential between ground beef with and without the additive has been estimated at approximately 3%.
== History == Bodybuilding.com grew out of wholesale-creatine.com, an online storefront created by teenage web marketer and amateur bodybuilder Ryan DeLuca in 1997, to capitalize on the rising popularity of creatine supplements. A majority stake in Bodybuilding.com was acquired in July 2006 by Milestone Partners for an undisclosed amount. In 2007, an FDA agent purchased several supplements from Bodybuilding.com which were determined to contain anabolic steroids. In May 2012, the company was fined $7 million, and as part of the settlement, CEO DeLuca and his brother Jeremy were both fined $600,000 for selling misbranded drugs. In January 2008, Liberty Media Corporation acquired a controlling stake in Bodybuilding.com for more than $100 million. DeLuca stayed on as the company's CEO.
Faure Essozimna Gnassingbé (French pronunciation: [fɔʁ esozimna ɲasiŋɡbe]; born 6 June 1966) is a Togolese politician who has led Togo since 2005, first as the fourth president until 2025 and then as president of the Council of Ministers. A member of the ruling Union for the Republic (UNIR), he is the son of the third president, Gnassingbé Eyadéma. Born in Afagnan, Gnassingbé studied in the United States and France before joining the Rally of the Togolese People (RPT) in 1990. He was appointed by his father as Minister of Equipment, Mines, Posts, and Telecommunications, serving in these roles from 2003 to 2005. Following Eyadéma's death in 2005, Gnassingbé was immediately installed as president with support from the army and was elected president of the National Assembly to further legitimise his succession. However, doubts regarding the constitutional legitimacy of the succession led to heavy regional pressure being placed on Gnassingbé, and he subsequently resigned on 25 February. He then won a controversial presidential election on 24 April, and was sworn in as president. Gnassingbé further ran for three more terms in 2010, 2015 and 2020, after a 2019 constitutional amendment which allowed him to run for two more terms. In 2024, Gnassingbé once again amended Togo's constitution, transferring most of the presidency's powers to the position of prime minister, which was officially reconstituted as "president of the Council of Ministers", nominally turning Togo from a presidential republic into a parliamentary one.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide analog of angiotensin IV, often described as an HGF mimetic in research literature. It is studied for effects on synaptic connectivity in laboratory models. It is not an approved medication.
No, dihexa is a synthetic compound derived from the structure of angiotensin IV. Angiotensin IV occurs naturally, but dihexa has modifications that change its properties. It is not a standard dietary component.
The main hypothesis is that dihexa interacts with the hepatocyte growth factor system, possibly through c-Met signaling. This interaction may influence synaptogenesis and neuronal plasticity. The exact molecular target remains an active area of study.
Dihexa is a synthetic peptide analog related to angiotensin IV. It is studied in preclinical research for effects on neural signaling and synapse formation. It is not an approved medicine.